IDEXX Laboratories, Inc.
515.15USD
-5.0600 (-0.97%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,217 | 1,141 | 1,091 | 1,105 | 1,109 | 998 | 954 | 976 |
| Cost of Revenue | 437 | 418 | 432 | 422 | 415 | 375 | 384 | 380 |
| Gross Profit | 779 | 723 | 658 | 683 | 695 | 623 | 571 | 596 |
| Operating Income | 426 | 363 | 316 | 355 | 373 | 317 | 262 | 304 |
| Net Income | 338 | 278 | 248 | 275 | 294 | 243 | 216 | 233 |
| EPS (Diluted) | $4.27 | $3.47 | $3.09 | $3.40 | $3.63 | $2.96 | $2.62 | $2.80 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)